Qube Research & Technologies (QRT)
HCA icon

Qube Research & Technologies (QRT)’s HCA Healthcare HCA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
7,900
+3,800
+93% +$1.61M ﹤0.01% 1883
2026
Q1 		$1.94M Buy
4,100
+500
+14% +$252K ﹤0.01% 2193
2025
Q4 		$1.68M Sell
3,600
-400
-10% -$186K ﹤0.01% 2331
2025
Q3 		$1.7M Sell
4,000
-100
-2% -$38.8K ﹤0.01% 2304
2025
Q2 		$1.57M Buy
4,100
+3,800
+1,267% +$1.37M ﹤0.01% 2293
2025
Q1 		$104K Sell
300
-1,500
-83% -$482K ﹤0.01% 3002
2024
Q4 		$540K Buy
1,800
+1,400
+350% +$489K ﹤0.01% 2436
2024
Q3 		$163K Buy
+400
New +$146K ﹤0.01% 2647
2024
Q1 		– Sell
-2,700
Closed -$731K – 4639
2023
Q4 		$731K Sell
2,700
-22,200
-89% -$5.49M ﹤0.01% 2095
2023
Q3 		$6.12M Buy
24,900
+24,500
+6,125% +$6.7M 0.02% 846
2023
Q2 		$121K Buy
+400
New +$111K ﹤0.01% 1913

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HCA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its HCA Healthcare (HCA) stake by 52% in Q2 2026, selling an estimated $40.1M and leaving 89,020 shares worth $34.7M. The position accounts for 0.03% of the portfolio, ranked #643.

Qube Research & Technologies (QRT) first reported a position in HCA in Q2 2018 and has held it in 25 quarters since. The position peaked at $310M in Q4 2024. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 89,020 shares of HCA Healthcare worth $34.7M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 94,850 HCA Healthcare shares in Q2 2026, an estimated $40.1M.
  • HCA Healthcare made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #643 holding.
  • Qube Research & Technologies (QRT) first reported a position in HCA Healthcare in Q2 2018 and has held it in 25 quarters since.
  • Qube Research & Technologies (QRT)'s HCA Healthcare position peaked at $310M in Q4 2024.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.